85 related articles for article (PubMed ID: 2415795)
1. Influence of blood proteins on biomedical analysis. VIII. Attempts at purification of gliclazide-degrading factor in human serum.
Kobayashi K; Hase A; Kimura M; Sakoguchi T; Shimosawa M; Matsuoka A
Life Sci; 1985 Nov; 37(21):2015-9. PubMed ID: 2415795
[TBL] [Abstract][Full Text] [Related]
2. Influence of blood proteins on biomedical analysis. III. Pharmacokinetics and protein binding of gliclazide.
Kobayashi K; Kimura M; Sakoguchi T; Kitani Y; Hata M; Matsuoka A
J Pharmacobiodyn; 1981 Jun; 4(6):436-42. PubMed ID: 7288560
[TBL] [Abstract][Full Text] [Related]
3. Influence of blood proteins on biomedical analysis. IV. Degradation of gliclazide in albumin-removed human serum and its protective effect of albumin.
Kobayashi K; Kimura M; Sakoguchi T; Kitani Y; Hase A; Matsuoka A
J Pharmacobiodyn; 1981 Nov; 4(11):886-92. PubMed ID: 7328490
[No Abstract] [Full Text] [Related]
4. [Determination of serum gliclazide (hypoglycemic drug) by high performance liquid chromatography, using diaion CDR-10 column].
Kobayashi K; Kimura M; Sakoguchi T; Kitani Y; Takashima S; Mimura K; Matsuoka A; Kimura Y
Rinsho Byori; 1981 Sep; 29(9):895-901. PubMed ID: 7328815
[No Abstract] [Full Text] [Related]
5. [Adsorption of gliclazide on the collodion membrane in ultrafiltration].
Kobayashi K; Kimura M; Hase A; Sakoguchi T; Hashimoto M; Matsuoka A
Rinsho Byori; 1985 May; 33(5):569-71. PubMed ID: 4057640
[No Abstract] [Full Text] [Related]
6. Influence of blood proteins on biomedical analysis. IX. Protective effects of human serum proteins on anion-induced degradation of gliclazide.
Kobayashi K; Igaki A; Kimura M; Sakoguchi T; Shimosawa M; Matsuoka A
Chem Pharm Bull (Tokyo); 1986 Jul; 34(7):2957-62. PubMed ID: 3769097
[No Abstract] [Full Text] [Related]
7. Comparison of biochemical properties of human serum B12 binders derived from sephadex and DEAE-cellulose chromatography.
Kumar S; Meyer LM; Gams RA
Scand J Haematol; 1977 May; 18(5):403-12. PubMed ID: 877516
[TBL] [Abstract][Full Text] [Related]
8. Influence of blood proteins on biomedical analysis. II. Interaction of gliclazide with bovine serum albumin.
Kobayashi K; Sakoguchi T; Kimura M; Kitani Y; Matsuoka A
Chem Pharm Bull (Tokyo); 1981 Feb; 29(2):573-7. PubMed ID: 7273254
[No Abstract] [Full Text] [Related]
9. Determination of gliclazide in human serum by high-performance liquid chromatography using an anion-exchange resin.
Kimura M; Kobayashi K; Hata M; Matsuoka A; Kitamura H; Kimura Y
J Chromatogr; 1980 Oct; 183(4):467-73. PubMed ID: 7430298
[TBL] [Abstract][Full Text] [Related]
10. Determination of a new hypoglycemic drug, gliclazide, in human serum by radioimmunoassay.
Suzuki H; Miki M; Sekine Y; Kagemoto A; Negoro T; Maeda T; Hashimoto M
J Pharmacobiodyn; 1981 Mar; 4(3):217-25. PubMed ID: 7252771
[TBL] [Abstract][Full Text] [Related]
11. Proteochondroitin sulfate A in the euglobulin fraction of human plasma.
Endo M; Namiki O; Yosizawa Z
J Biochem; 1976 Jan; 79(1):5-10. PubMed ID: 133103
[TBL] [Abstract][Full Text] [Related]
12. Influence of blood proteins on biomedical analysis. V. Effect of ethyl alcohol on gliclazide-binding with bovine serum albumin.
Kobayashi K; Kimura M; Sakoguchi T; Hase A; Matsuoka A
Chem Pharm Bull (Tokyo); 1982 Mar; 30(3):1077-80. PubMed ID: 7094168
[No Abstract] [Full Text] [Related]
13. Measurement of gliclazide in plasma by radial compression reversed-phase liquid chromatography.
Charles BG; Ravenscroft PJ
Clin Chem; 1984 Nov; 30(11):1789-91. PubMed ID: 6488522
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of gliclazide in healthy and diabetic subjects.
Kobayashi K; Kimura M; Sakoguchi T; Hase A; Matsuoka A; Kaneko S
J Pharm Sci; 1984 Dec; 73(12):1684-7. PubMed ID: 6396398
[TBL] [Abstract][Full Text] [Related]
15. Drug interactions of gliclazide and other sulfonylureas in protein binding in vitro and in hypoglycemic effect in rats.
Fujii T; Nakamura K; Furukawa H; Watanabe M; Kuwashima J; Miyazaki H; Kawashima K; Kuzuya T
Arzneimittelforschung; 1983; 33(11):1535-7. PubMed ID: 6686448
[TBL] [Abstract][Full Text] [Related]
16. [High-performance liquid chromatographic determination of gliclazide (oral hypoglycemic agent) in serum--trial of sensitive fluorometric determination].
Igaki A; Kobayashi K; Kimura M; Sakoguchi T; Hashimoto M; Matsuoka A
Rinsho Byori; 1986 Feb; 34(2):201-5. PubMed ID: 3702090
[No Abstract] [Full Text] [Related]
17. High-performance liquid chromatographic determination of gliclazide in human plasma.
Poirier JM; Perez M; Cheymol G
J Chromatogr; 1987 Oct; 421(1):223-6. PubMed ID: 3429572
[No Abstract] [Full Text] [Related]
18. Reversed-phase high-performance liquid chromatographic determination of gliclazide in human plasma.
Kimura M; Kobayashi K; Hata M; Matsuoka A; Kaneko S; Kitamura H; Kimura Y
Chem Pharm Bull (Tokyo); 1980 Jan; 28(1):344-6. PubMed ID: 7363377
[No Abstract] [Full Text] [Related]
19. [Gas-liquid chromatographic method for determination of plasma gliclazide (author's transl)].
Kimura M; Kobayashi K; Takashima S; Ino T; Hata M; Matsuoka A; Kaneko S; Kimura Y
Rinsho Byori; 1980 Jan; 28(1):63-6. PubMed ID: 7373877
[No Abstract] [Full Text] [Related]
20. Gas chromatographic determination of the hypoglycaemic agent gliclazide in plasma.
Maeda T; Yamaguchi T; Hashimoto M
J Chromatogr; 1981 May; 223(2):357-63. PubMed ID: 7251790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
